Fenvalerate

Fenvalerate

SCHEMBL3681087

CC(C)C(C(=O)O[C@H](C#N)c1cccc(Oc2ccccc2)c1)c1ccc(Cl)cc1

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.52
TDP1 Q9NUW8 1/20 0.52
ALOX5 P09917 2/20 0.46
PTGS1 P23219 1/20 0.46
MEN1 O00255 1/20 0.46
CYP2D6 P10635 1/20 0.46
KMT2A Q03164 1/20 0.46
LMNA P02545 1/20 0.41
CCR1 P32246 1/20 0.40
PPARG P37231 1/20 0.39
PPARA Q07869 1/20 0.39
MAPT P10636 1/20 0.38
HPGD P15428 1/20 0.38
ACACB O00763 1/20 0.38
ACACA Q13085 1/20 0.38
FFAR2 O15552 2/20 0.37
NPY5R Q15761 1/20 0.37
AKR1C3 P42330 1/20 0.36
EGLN2 Q96KS0 1/20 0.36
EGLN1 Q9GZT9 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fenvalerate SCHEMBL29422205 1.00 ALDH1A1 (0.52) ALDH1A1TDP1ALOX5PTGS1MEN1
Fenvalerate SCHEMBL3880683 1.00 ALDH1A1 (0.52) ALDH1A1TDP1ALOX5PTGS1MEN1
Fenvalerate SCHEMBL31733926 1.00 ALDH1A1 (0.52) ALDH1A1TDP1ALOX5PTGS1MEN1
Fenvalerate SCHEMBL26507 1.00 ALDH1A1 (0.52) ALDH1A1TDP1ALOX5PTGS1MEN1
Fenvalerate SCHEMBL1765690 1.00 ALDH1A1 (0.52) ALDH1A1TDP1ALOX5PTGS1MEN1
Fenvalerate SCHEMBL10586134 1.00 ALDH1A1 (0.52) ALDH1A1TDP1ALOX5PTGS1MEN1
Fenvalerate SCHEMBL3513129 1.00 ALDH1A1 (0.52) ALDH1A1TDP1ALOX5PTGS1MEN1
Fenvalerate SCHEMBL10585702 1.00 ALDH1A1 (0.52) ALDH1A1TDP1ALOX5PTGS1MEN1
Fenvalerate SCHEMBL4060133 1.00 ALDH1A1 (0.52) ALDH1A1TDP1ALOX5PTGS1MEN1
Fenvalerate SCHEMBL29352031 1.00 ALDH1A1 (0.52) ALDH1A1TDP1ALOX5PTGS1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100179196-A1 COMPOSITIONS AND METHODS FOR DEPLOYING A TRANSGENIC REFUGE AS A SEED BLEND PERSHING JAY C 2010-07-15 US claimed
EP-1566996-B1 METHOD OF PROTECTING SEEDS TREATED WITH A PHYTOTOXIC AGENT MONSANTO TECHNOLOGY LLC (US) 2009-11-11 EP claimed
US-7560585-B2 Process for preparing (S)- alpha-cyano-3-phenoxybenzyl-(S)-2-(4-chlorophenyl)-isovalerate COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2009-07-14 US claimed
EP-1322166-B1 SEED TREATMENT WITH COMBINATIONS OF INSECTICIDES MONSANTO TECHNOLOGY LLC (US) 2007-04-25 EP claimed
US-20060128982-A1 Process for preparing (S)- alpha-cyano-3-phenoxybenzyl-(S)-2-(4-chlorophenyl)-isovalerate COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH 2006-06-15 US claimed
WO-2006010994-A1 PROCESS FOR PREPARING (S)-ALPHA-CYANO-3-PHENOXYBENZYL-(S)-2-(4-CHLOROPHENYL)-ISOVALERATE COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2006-02-02 WO claimed
US-20050197251-A1 Method of controlling the release of agricultural active ingredients from treated plant seeds MONSANTO TECHNOLOGY, L.L.C. (US) 2005-09-08 US claimed
WO-2002080675-A9 TREATED PLANT SEEDS WITH CONTROLLED RELEASE OF ACTIVE AGENTS MONSANTO TECHNOLOGY LLC (US) 2004-05-06 WO claimed
EP-1370136-A1 TREATED PLANT SEEDS WITH CONTROLLED RELEASE OF ACTIVE AGENTS Monsanto Technology LLC (US) 2003-12-17 EP claimed
WO-2002080675-A1 TREATED PLANT SEEDS WITH CONTROLLED RELEASE OF ACTIVE AGENTS MONSANTO TECHNOLOGY, LLC (US) 2002-10-17 WO claimed
US-20020134012-A1 Method of controlling the release of agricultural active ingredients from treated plant seeds MONSANTO TECHNOLOGY, L.L.C. 2002-09-26 US claimed
US-4668511-A PHOTOSTABILITY, PYRETHRINOID, BACULOVIRUS INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (FR) 1987-05-26 US claimed
US-7560585-B2 Process for preparing (S)- alpha-cyano-3-phenoxybenzyl-(S)-2-(4-chlorophenyl)-isovalerate COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2009-07-14 US disclosed
US-7560585-B2 Process for preparing (S)- alpha-cyano-3-phenoxybenzyl-(S)-2-(4-chlorophenyl)-isovalerate COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2009-07-14 US disclosed
US-7560585-B2 Process for preparing (S)- alpha-cyano-3-phenoxybenzyl-(S)-2-(4-chlorophenyl)-isovalerate COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2009-07-14 US disclosed
US-20060128982-A1 Process for preparing (S)- alpha-cyano-3-phenoxybenzyl-(S)-2-(4-chlorophenyl)-isovalerate COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH 2006-06-15 US disclosed
US-4761494-A Preparation of cyanomethyl esters E. I. DU PONT DE NEMOURS AND COMPANY (US) 1988-08-02 US disclosed
EP-0172380-A2 Preparation of cyanomethyl esters E.I. DU PONT DE NEMOURS AND COMPANY (US) 1986-02-26 EP disclosed
US-4526727-A Treating racemic R,S-alpha isopropylphenylacetic acid with an S-alpha cyano-3-phenoxybenzyl alcohol SHELL OIL COMPANY (US) 1985-07-02 US disclosed
US-4276308-A ALPHA-CYANO-3-PHENOXY-BENZYL CARBOXYLATES SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1981-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060128982-A1 Process for preparing (S)- alpha-cyano-3-phenoxybenzyl-(S)-2-(4-chlorophenyl)-isovalerate PCCA, CHRNE, CHRNB4 ALDH1A1 3095/4885TDP1 3528/4885ALOX5 4011/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.